{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:25:22Z","timestamp":1776205522888,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11357-020-00314-w","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T23:02:18Z","timestamp":1611010938000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Age-associated difference in circulating ACE2, the gateway for SARS-COV-2, in humans: results from the InCHIANTI study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7642-2643","authenticated-orcid":false,"given":"Majd","family":"AlGhatrif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Zenobia","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Bandinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward G.","family":"Lakatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"314_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","volume":"69","author":"S Bialek","year":"2020","unstructured":"Bialek S, et al. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)\u2014United States, February 12\u2013March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"314_CR2","doi-asserted-by":"publisher","first-page":"m606","DOI":"10.1136\/bmj.m606","volume":"368","author":"X-W Xu","year":"2020","unstructured":"Xu X-W, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.","journal-title":"BMJ"},{"key":"314_CR3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.15585\/mmwr.mm6939e1","volume":"69","author":"TK Boehmer","year":"2020","unstructured":"Boehmer TK, DeVies J, Caruso E, van Santen KL, Tang S, Black CL, et al. Changing age distribution of the COVID-19 pandemic\u2014United States, May\u2013August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1404\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"314_CR4","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/cid\/cix1060","volume":"66","author":"JI Tokars","year":"2018","unstructured":"Tokars JI, Olsen SJ, Reed C. Seasonal incidence of symptomatic influenza in the United States. Clin Infect Dis. 2018;66:1511\u20138.","journal-title":"Clin Infect Dis"},{"key":"314_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamacardio.2020.1329","volume":"5","author":"M AlGhatrif","year":"2020","unstructured":"AlGhatrif M, Cingolani O, Lakatta EG. The dilemma of coronavirus disease 2019, aging, and cardiovascular disease insights from cardiovascular aging science. JAMA Cardiol. 2020;5:747\u20138.","journal-title":"JAMA Cardiol"},{"key":"314_CR6","doi-asserted-by":"publisher","unstructured":"Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X COVID-19 and the cardiovascular system. Nat Rev Cardiol 1\u20132 (2020) doi:https:\/\/doi.org\/10.1038\/s41569-020-0360-5","DOI":"10.1038\/s41569-020-0360-5"},{"key":"314_CR7","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","volume":"78","author":"X Xudong","year":"2006","unstructured":"Xudong X, Junzhu C, Xingxiang W, Furong Z, Yanrong L. Age- and gender-related difference of ACE2 expression in rat lung. Life Sci. 2006;78:2166\u201371.","journal-title":"Life Sci"},{"key":"314_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3201\/eid1001.030553","volume":"10","author":"W Liang","year":"2004","unstructured":"Liang W, Zhu Z, Guo J, Liu Z, He X, Zhou W, et al. Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis. 2004;10:25\u201331.","journal-title":"Emerg Infect Dis"},{"key":"314_CR9","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1001\/jama.2020.8707","volume":"323","author":"S Bunyavanich","year":"2020","unstructured":"Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA. 2020;323:2427\u20139.","journal-title":"JAMA"},{"key":"314_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, et al. Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1\/2 and NF-\u03baB signaling pathways. Sci Rep. 2016;6:1\u201314.","journal-title":"Sci Rep"},{"key":"314_CR11","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653\u20139.","journal-title":"N Engl J Med"},{"key":"314_CR12","doi-asserted-by":"publisher","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","volume":"7","author":"J Candia","year":"2017","unstructured":"Candia J, Cheung F, Kotliarov Y, Fantoni G, Sellers B, Griesman T, et al. Assessment of variability in the SOMAscan assay. Sci Rep. 2017;7:14248.","journal-title":"Sci Rep"},{"key":"314_CR13","doi-asserted-by":"publisher","first-page":"e12799","DOI":"10.1111\/acel.12799","volume":"17","author":"T Tanaka","year":"2018","unstructured":"Tanaka T, Biancotto A, Moaddel R, Moore AZ, Gonzalez-Freire M, Aon MA, et al. Plasma proteomic signature of age in healthy humans. Aging Cell. 2018;17:e12799.","journal-title":"Aging Cell"},{"key":"314_CR14","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","volume":"126","author":"V Aboyans","year":"2012","unstructured":"Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126:2890\u2013909.","journal-title":"Circulation"},{"key":"314_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jamda.2015.03.013","volume":"16","author":"E Fabbri","year":"2015","unstructured":"Fabbri E, Zoli M, Gonzalez-Freire M, Salive ME, Studenski SA, Ferrucci L. Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc. 2015;16:640\u20137.","journal-title":"J Am Med Dir Assoc"},{"key":"314_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","volume":"66","author":"VB Patel","year":"2014","unstructured":"Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, Basu R, et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol. 2014;66:167\u201376.","journal-title":"J Mol Cell Cardiol"},{"key":"314_CR17","unstructured":"Aging healthy, or with diabetes, is associated with ACE2\/ACE imbalance in the hematopoietic stem progenitor cells | The FASEB Journal. https:\/\/www.fasebj.org\/doi\/abs\/10.1096\/fasebj.2019.33.1_supplement.514.7."},{"key":"314_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2013.10.002","volume":"25","author":"M Wang","year":"2014","unstructured":"Wang M, Jiang L, Monticone RE, Lakatta EG. Proinflammation: the key to arterial aging. Trends Endocrinol Metab. 2014;25:72\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"314_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41569-018-0068-y","volume":"15","author":"EG Lakatta","year":"2018","unstructured":"Lakatta EG. The reality of getting old. Nat Rev Cardiol. 2018;15:499\u2013500.","journal-title":"Nat Rev Cardiol"},{"key":"314_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Circulation. 2003;107:346\u201354.","journal-title":"Circulation"},{"key":"314_CR21","unstructured":"Coronavirus: why it\u2019s so deadly in Italy - Andreas Backhaus - Medium. https:\/\/medium.com\/@andreasbackhausab\/coronavirus-why-its-so-deadly-in-italy-c4200a15a7bf."},{"key":"314_CR22","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.peptides.2010.03.026","volume":"31","author":"CS Lin","year":"2010","unstructured":"Lin CS, Pan CH, Wen CH, Yang TH, Kuan TC. Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts. Peptides. 2010;31:1334\u201340.","journal-title":"Peptides"},{"key":"314_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21.","journal-title":"Lancet Respir Med"},{"key":"314_CR24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621","volume":"382","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020;382:e102.","journal-title":"N Engl J Med"},{"key":"314_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jama.2020.11301","volume":"324","author":"EL Fosb\u00f8l","year":"2020","unstructured":"Fosb\u00f8l EL, Butt JH, \u00d8stergaard L, Andersson C, Selmer C, Kragholm K, et al. Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. JAMA - J Am Med Assoc. 2020;324:168\u201377.","journal-title":"JAMA - J Am Med Assoc"},{"key":"314_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, et al. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020;9:757\u201360.","journal-title":"Emerg Microbes Infect"},{"key":"314_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","volume":"69","author":"N Chow","year":"2020","unstructured":"Chow N, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019\u2014United States, February 12\u2013March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:382\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"314_CR28","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/S0140-6736(20)31024-2","volume":"395","author":"DA Kass","year":"2020","unstructured":"Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet. 2020;395:1544\u20135.","journal-title":"Lancet"},{"key":"314_CR29","unstructured":"Obesity linked to severe coronavirus disease, especially for younger patients - The New York Times. https:\/\/www.nytimes.com\/2020\/04\/16\/health\/coronavirus-obesity-higher-risk.html."},{"key":"314_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/FJC.0b013e3180986219","volume":"50","author":"MK Raizada","year":"2007","unstructured":"Raizada MK, Ferreira AJ. ACE2: a new target for cardiovascular disease therapeutics. J Cardiovasc Pharmacol. 2007;50:112\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"key":"314_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.2162","volume":"212","author":"I Hamming","year":"2007","unstructured":"Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus ADME, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212:1\u201311.","journal-title":"J Pathol"},{"key":"314_CR32","doi-asserted-by":"publisher","first-page":"e87845","DOI":"10.1371\/journal.pone.0087845","volume":"9","author":"K \u00dari","year":"2014","unstructured":"\u00dari K, Fagyas M, M\u00e1nyin\u00e9 Siket I, Kert\u00e9sz A, Csan\u00e1di Z, S\u00e1ndorfi G, et al. New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PLoS One. 2014;9:e87845.","journal-title":"PLoS One"},{"key":"314_CR33","doi-asserted-by":"crossref","unstructured":"\u00dari K et al. Circulating ACE2 activity correlates with cardiovascular disease development. JRAAS - J Renin-Angiotensin-Aldosterone Syst 17, (2016).","DOI":"10.1177\/1470320316668435"},{"key":"314_CR34","doi-asserted-by":"publisher","unstructured":"Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. (2018) doi:https:\/\/doi.org\/10.1371\/journal.pone.0198144.","DOI":"10.1371\/journal.pone.0198144"},{"key":"314_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","volume":"15","author":"S Epelman","year":"2009","unstructured":"Epelman S, Shrestha K, Troughton RW, Francis GS, Sen S, Klein AL, et al. Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail. 2009;15:565\u201371.","journal-title":"J Card Fail"},{"key":"314_CR36","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/ndt\/gfv025","volume":"30","author":"L Anguiano","year":"2015","unstructured":"Anguiano L, Riera M, Pascual J, Valdivielso JM, Barrios C, Betriu A, et al. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease. Nephrol Dial Transplant. 2015;30:1176\u201385.","journal-title":"Nephrol Dial Transplant"},{"key":"314_CR37","doi-asserted-by":"publisher","unstructured":"Wang M, Jiang L, Monticone RE, Lakatta EG Proinflammation: the key to arterial aging Chronic inflammation and arterial aging doi:https:\/\/doi.org\/10.1016\/j.tem.2013.10.002, 2014.","DOI":"10.1016\/j.tem.2013.10.002"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-020-00314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-020-00314-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-020-00314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T19:17:50Z","timestamp":1620760670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-020-00314-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1007\/s11357-020-00314-w","relation":{},"ISSN":["2509-2715","2509-2723"],"issn-type":[{"value":"2509-2715","type":"print"},{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}